At Pharmabiotics 2026, David Suissa, CEO of BYOME LABS, discussed the growing interest in microbiome research, from the gut and vaginal ecosystems to the less explored skin, scalp and oral microbiomes. He highlighted the need to translate fundamental research and biomarker discovery into diagnostic tools that are affordable, rapid and easy to use in everyday settings. Inspired by the simplicity of COVID-19 antigen tests, BYOME LABS is developing microbiome-based tests designed to provide results within minutes, either at home, at a pharmacy, in a cosmetics store or at the point of care. The aim is to enable consumers to assess their skin or scalp microbiome over time and receive guidance toward products suited to their individual profile. After its initial focus on skin and scalp, the company plans to expand this approach to the oral and vaginal microbiomes, opening new possibilities for accessible and personalized microbiome care.